Therapeutic Drug Monitoring
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.3 | Q2 | 60.6% | 0.587 | Q2 | 66.8% |
| 2024 | 2.4 | Q2 | 60.6% | 0.585 | Q2 | 67.6% |
| 2023 | 2.8 | Q2 | 52.4% | 0.591 | Q2 | 70.5% |
| 2022 | 2.5 | Q2 | 31.6% | 0.466 | Q3 | 64.1% |
| 2021 | 3.1 | Q3 | 43.3% | 0.555 | Q2 | 70.4% |
| 2020 | — | — | 0.649 | Q2 | 74.0% | |
| 2019 | — | — | 0.549 | Q2 | 70.1% | |
| 2018 | — | — | 0.613 | Q2 | 71.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0163-4356
ISSN
1536-3694
country
UScoverage
1979-2026